Pulmonary complications of bone-marrow and stem-cell transplantation

Bekele Afessa, Andrew David Badley, Steve G. Peters

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Tens of thousands of patients undergo haematopoietic stem-cell transplantation (HSCT) annually, primarily for haematological and lymphoid cancers, but also for other disorders.1 Intensive care support is provided for 15-40 per cent of HSCT recipients, most of whom require mechanical ventilation for respiratory failure.2 Although recent studies have shown improvement in outcome, the mortality rate of HSCT recipients receiving invasive ventilation may exceed 90 per cent. This chapter describes the pulmonary complications that develop in HSCT recipients.

Original languageEnglish (US)
Title of host publicationDrug-Induced and Iatrogenic Respiratory Disease
PublisherCRC Press
Pages172-191
Number of pages20
ISBN (Electronic)9781444128697
ISBN (Print)9780340809730
StatePublished - Jan 1 2010

Fingerprint

transplantation
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Bone Marrow Transplantation
bone
Lung
ventilation
Critical Care
Artificial Respiration
Ventilation
cancer
mortality
Mortality
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Environmental Science(all)

Cite this

Afessa, B., Badley, A. D., & Peters, S. G. (2010). Pulmonary complications of bone-marrow and stem-cell transplantation. In Drug-Induced and Iatrogenic Respiratory Disease (pp. 172-191). CRC Press.

Pulmonary complications of bone-marrow and stem-cell transplantation. / Afessa, Bekele; Badley, Andrew David; Peters, Steve G.

Drug-Induced and Iatrogenic Respiratory Disease. CRC Press, 2010. p. 172-191.

Research output: Chapter in Book/Report/Conference proceedingChapter

Afessa, B, Badley, AD & Peters, SG 2010, Pulmonary complications of bone-marrow and stem-cell transplantation. in Drug-Induced and Iatrogenic Respiratory Disease. CRC Press, pp. 172-191.
Afessa B, Badley AD, Peters SG. Pulmonary complications of bone-marrow and stem-cell transplantation. In Drug-Induced and Iatrogenic Respiratory Disease. CRC Press. 2010. p. 172-191
Afessa, Bekele ; Badley, Andrew David ; Peters, Steve G. / Pulmonary complications of bone-marrow and stem-cell transplantation. Drug-Induced and Iatrogenic Respiratory Disease. CRC Press, 2010. pp. 172-191
@inbook{cbbdf181db494ad7bb7aeb657cb3269c,
title = "Pulmonary complications of bone-marrow and stem-cell transplantation",
abstract = "Tens of thousands of patients undergo haematopoietic stem-cell transplantation (HSCT) annually, primarily for haematological and lymphoid cancers, but also for other disorders.1 Intensive care support is provided for 15-40 per cent of HSCT recipients, most of whom require mechanical ventilation for respiratory failure.2 Although recent studies have shown improvement in outcome, the mortality rate of HSCT recipients receiving invasive ventilation may exceed 90 per cent. This chapter describes the pulmonary complications that develop in HSCT recipients.",
author = "Bekele Afessa and Badley, {Andrew David} and Peters, {Steve G.}",
year = "2010",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780340809730",
pages = "172--191",
booktitle = "Drug-Induced and Iatrogenic Respiratory Disease",
publisher = "CRC Press",

}

TY - CHAP

T1 - Pulmonary complications of bone-marrow and stem-cell transplantation

AU - Afessa, Bekele

AU - Badley, Andrew David

AU - Peters, Steve G.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Tens of thousands of patients undergo haematopoietic stem-cell transplantation (HSCT) annually, primarily for haematological and lymphoid cancers, but also for other disorders.1 Intensive care support is provided for 15-40 per cent of HSCT recipients, most of whom require mechanical ventilation for respiratory failure.2 Although recent studies have shown improvement in outcome, the mortality rate of HSCT recipients receiving invasive ventilation may exceed 90 per cent. This chapter describes the pulmonary complications that develop in HSCT recipients.

AB - Tens of thousands of patients undergo haematopoietic stem-cell transplantation (HSCT) annually, primarily for haematological and lymphoid cancers, but also for other disorders.1 Intensive care support is provided for 15-40 per cent of HSCT recipients, most of whom require mechanical ventilation for respiratory failure.2 Although recent studies have shown improvement in outcome, the mortality rate of HSCT recipients receiving invasive ventilation may exceed 90 per cent. This chapter describes the pulmonary complications that develop in HSCT recipients.

UR - http://www.scopus.com/inward/record.url?scp=85055828037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055828037&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85055828037

SN - 9780340809730

SP - 172

EP - 191

BT - Drug-Induced and Iatrogenic Respiratory Disease

PB - CRC Press

ER -